As of the close on September 10, 2024, BiVictriX Therapeutics Plc's stock has declined approximately 28.57% over the past 52 weeks. The 50-day moving average sits at 10.99, while the 200-day moving average is 11.32.
| 52-Week Price Change | -28.57% |
| 50-Day Moving Average | 10.99 |
| 200-Day Moving Average | 11.32 |
Already premium?